New Delhi NCR healthtech startups raise $917 million in H1 2026 despite funding dip
New Delhi NCR’s healthtech startups raised $917 million across 134 deals in the first half of 2026, a 39% year-on-year decline in funding value but a 16% increase in deal count, according to Inc42. The region’s performance reflects national trends, with projected growth driven by wearables, preventive care, and teleconsultations.
Editor, Lazyfounder

TABLE OF CONTENTS
Funding trends in New Delhi NCR healthtech
According to Inc42, New Delhi NCR healthtech startups raised $917 million across 134 deals in the first half of 2026. This represents a 39% year-on-year decline in funding value but a 16% increase in the number of deals.
The region’s funding activity mirrors national trends. India’s healthtech sector raised about $700 million across 54 deals in 2025, down from 78 deals in 2024, after ranking as the fourth most funded sector in 2024 with over $700 million raised.
Over the past decade, Indian healthtech startups have secured slightly over $7 billion across 886 deals, per Inc42’s data.
Projected market growth
Inc42 projects the Indian healthtech market will grow at a 39% compound annual growth rate (CAGR) to reach $37 billion by 2030. This growth is attributed to post-pandemic trends such as increased adoption of wearables, preventive care, and teleconsultations.
Leading startups in the ecosystem
New Delhi NCR hosts around 80 healthtech startups, with Clove Dental, BeatO, and NirogStreet leading in funding. Clove Dental has raised $117 million, BeatO $47.6 million, and NirogStreet $36.8 million, according to Inc42’s ranking of the top 30 funded startups in the city.
The ecosystem includes startups across specialties such as dental care, diabetes management, mental wellness, and hospital management. Newer players are emerging in AI-driven health solutions, including Sychedelic, which raised $3.5 million in seed funding for AI-powered mental wellness headphones.
Broader startup policy context
New Delhi’s startup policy aims to position the city as India’s premier startup hub by 2030. The capital’s ecosystem supports early and growth-stage activity across consumer, SaaS, and health-focused startups, as reported by Inc42.
What this means
Lazyfounder analysis — our interpretation, not reported fact.
New Delhi NCR’s healthtech funding slowdown in H1 2026 reflects a broader pullback in Indian startup investments, but the rise in deal count signals continued investor interest in early-stage and smaller-ticket opportunities. For founders, this means competition for larger rounds remains intense, while seed and Series A stages may offer more accessible funding. The projected 39% CAGR to 2030 underscores the sector’s long-term potential, particularly for startups leveraging AI, wearables, or preventive care—areas already attracting capital in the region.
Sources
This story is an original summary drafted with AI by Lazyfounder from the reporting listed above and checked by automated validation. Facts are attributed to their original publishers; sections marked as analysis are Lazyfounder's. Where a source is in another language, facts were machine-translated and quotations are reported, not reproduced. Read the original coverage via the links, and see our AI policy and corrections policy.
About the author
Editor, Lazyfounder
Tarun Mottlia edits LazyFounders, covering Indian startups, funding rounds, AI and product launches. Every story on the site is AI-assisted and checked against its cited sources before publication.
More stories by Tarun MottliaGet the LazyFounder Brief
Startup, funding and AI news in a five-minute read. Join the early-access list.


